Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
1.
Emerg Infect Dis ; 29(8): 1687-1690, 2023 08.
Article de Anglais | MEDLINE | ID: mdl-37352549

RÉSUMÉ

Since February 2022, Malawi has experienced a cholera outbreak of >54,000 cases. We investigated 6 cases in South Africa and found that isolates linked to the outbreak were Vibrio cholerae O1 serotype Ogawa from seventh pandemic El Tor sublineage AFR15, indicating a new introduction of cholera into Africa from south Asia.


Sujet(s)
Choléra , Vibrio cholerae O1 , Humains , Choléra/épidémiologie , République d'Afrique du Sud/épidémiologie , Vibrio cholerae O1/génétique , Asie du Sud , Malawi , Épidémies de maladies
2.
N Engl J Med ; 382(7): 632-643, 2020 02 13.
Article de Anglais | MEDLINE | ID: mdl-32053299

RÉSUMÉ

BACKGROUND: An outbreak of listeriosis was identified in South Africa in 2017. The source was unknown. METHODS: We conducted epidemiologic, trace-back, and environmental investigations and used whole-genome sequencing to type Listeria monocytogenes isolates. A case was defined as laboratory-confirmed L. monocytogenes infection during the period from June 11, 2017, to April 7, 2018. RESULTS: A total of 937 cases were identified, of which 465 (50%) were associated with pregnancy; 406 of the pregnancy-associated cases (87%) occurred in neonates. Of the 937 cases, 229 (24%) occurred in patients 15 to 49 years of age (excluding those who were pregnant). Among the patients in whom human immunodeficiency virus (HIV) status was known, 38% of those with pregnancy-associated cases (77 of 204) and 46% of the remaining patients (97 of 211) were infected with HIV. Among 728 patients with a known outcome, 193 (27%) died. Clinical isolates from 609 patients were sequenced, and 567 (93%) were identified as sequence type 6 (ST6). In a case-control analysis, patients with ST6 infections were more likely to have eaten polony (a ready-to-eat processed meat) than those with non-ST6 infections (odds ratio, 8.55; 95% confidence interval, 1.66 to 43.35). Polony and environmental samples also yielded ST6 isolates, which, together with the isolates from the patients, belonged to the same core-genome multilocus sequence typing cluster with no more than 4 allelic differences; these findings showed that polony produced at a single facility was the outbreak source. A recall of ready-to-eat processed meat products from this facility was associated with a rapid decline in the incidence of L. monocytogenes ST6 infections. CONCLUSIONS: This investigation showed that in a middle-income country with a high prevalence of HIV infection, L. monocytogenes caused disproportionate illness among pregnant girls and women and HIV-infected persons. Whole-genome sequencing facilitated the detection of the outbreak and guided the trace-back investigations that led to the identification of the source.


Sujet(s)
Épidémies de maladies , Maladies d'origine alimentaire/épidémiologie , Listeria monocytogenes/isolement et purification , Infections à Listeria/épidémiologie , Produits carnés/microbiologie , Adolescent , Adulte , Sujet âgé , Techniques de typage bactérien , Études cas-témoins , Femelle , Maladies d'origine alimentaire/étiologie , Maladies d'origine alimentaire/mortalité , Infections à VIH/complications , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Humains , Nouveau-né , Listeria monocytogenes/génétique , Infections à Listeria/étiologie , Infections à Listeria/mortalité , Mâle , Produits carnés/effets indésirables , Adulte d'âge moyen , Grossesse , Complications infectieuses de la grossesse/épidémiologie , Rappels et retraits de produits , Répartition par sexe , République d'Afrique du Sud/épidémiologie , Séquençage du génome entier , Jeune adulte
3.
Lancet Glob Health ; 3(8): e450-e457, 2015 Aug.
Article de Anglais | MEDLINE | ID: mdl-26187490

RÉSUMÉ

BACKGROUND: In South Africa, sputum smear microscopy has been replaced with Xpert MTB/RIF as the initial diagnostic test for tuberculosis. In a pragmatic parallel cluster-randomised trial, we evaluated the effect on patient and programme outcomes. METHODS: We randomly allocated 20 laboratories (clusters) in medium-burden districts of South Africa to either an Xpert (immediate Xpert) or microscopy (Xpert deferred) group (1:1), stratified by province. At two primary care clinics per laboratory, a systematic sample of adults giving sputum for tuberculosis investigation was assessed for eligibility. The primary outcome was mortality at 6 months from enrolment. Masking of participants' group allocation was not possible because of the pragmatic trial design. The trial is registered with the ISRCTN registry (ISRCTN68905568) and the South African Clinical Trial Register (DOH-27-1011-3849). FINDINGS: Between June and November, 2012, 4972 people were screened, and 4656 (93·6%) enrolled (median age 36 years; 2891 [62%] female; 2212 [62%] reported being HIV-positive). There was no difference between the Xpert and microscopy groups with respect to mortality at 6 months (91/2324 [3·9%] vs 116/2332 [5·0%], respectively; adjusted risk ratio [aRR] 1·10, 95% CI 0·75-1·62]). INTERPRETATION: Xpert did not reduce mortality at 6 months compared with sputum microscopy. Improving outcomes in drug-sensitive tuberculosis programmes might require not only better diagnostic tests but also better linkage to care. FUNDING: Bill & Melinda Gates Foundation.


Sujet(s)
Infections à VIH/diagnostic , Techniques de diagnostic moléculaire/méthodes , Expectoration/microbiologie , Tuberculose multirésistante/diagnostic , Tuberculose pulmonaire/diagnostic , Adulte , Analyse de variance , Antituberculeux/usage thérapeutique , Comorbidité , Résistance bactérienne aux médicaments/effets des médicaments et des substances chimiques , Résistance bactérienne aux médicaments/génétique , Détermination du point final , Femelle , Infections à VIH/épidémiologie , Humains , Mâle , Adulte d'âge moyen , Mortalité/tendances , Évaluation des résultats et des processus en soins de santé/méthodes , Évaluation des résultats et des processus en soins de santé/statistiques et données numériques , Rifampicine/usage thérapeutique , République d'Afrique du Sud , Tuberculose multirésistante/épidémiologie , Tuberculose multirésistante/mortalité , Tuberculose pulmonaire/épidémiologie , Tuberculose pulmonaire/mortalité
4.
J Pediatr Hematol Oncol ; 25(2): 167-8, 2003 Feb.
Article de Anglais | MEDLINE | ID: mdl-12571472

RÉSUMÉ

The progress of a female child with African type Fanconi anemia that evolves in time into paroxysmal nocturnal hemoglobinuria is described. Modern diagnostic methods are used to confirm this process. A discussion of possible mechanisms ensues.


Sujet(s)
Anémie de Fanconi/complications , Hémoglobinurie paroxystique/étiologie , Enfant , Érythrocytes/métabolisme , Érythrocytes/anatomopathologie , Anémie de Fanconi/sang , Femelle , Cytométrie en flux , Hémoglobinurie paroxystique/sang , Humains
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE